OPTICAL MODULE AND OPTICAL ENCODER
    2.
    发明申请

    公开(公告)号:US20200284620A1

    公开(公告)日:2020-09-10

    申请号:US16807585

    申请日:2020-03-03

    IPC分类号: G01D5/347 G01D5/30

    摘要: An optical module includes a fixed substrate, and a sensor substrate secured to the fixed substrate and having a through-hole formed therein. A light emitting device is secured to the fixed substrate at a position in the through-hole. A light receiving device is provided in the sensor substrate. A dummy light receiving device is formed between the light receiving device and the through-hole, around the through-hole, and in the sensor substrate. The light receiving device and the dummy light receiving device are made of an impurity diffusion layer having a same conductive type as a conductive type of a surface layer of the sensor substrate. The dummy light receiving device is deeper than the light receiving device.

    Battery protecting apparatus
    3.
    发明授权

    公开(公告)号:US10170919B2

    公开(公告)日:2019-01-01

    申请号:US15622272

    申请日:2017-06-14

    摘要: A battery protecting apparatus includes: a charging/discharging control chip including a charging control FET and a discharging control FET connected to a secondary battery; a protecting chip configured to control, based on a voltage between both ends of the secondary battery, the FETs to prevent overcharging, over discharging, and an overcurrent; and a lead frame having a connection surface for a plurality of external terminals and another surface in conduction with the connection surface. Said another surface is electrically connected, via a conductive material, to terminals of the FETs formed on a front surface of the charging/discharging control chip. A back surface of the protecting chip faces a back surface of the charging/discharging control chip via an insulative member. Terminals of the protecting chip are electrically connected to said another surface through bonding wires. The charging/discharging control chip and the protecting chip are covered by a resin.

    Synthetic N-linked sialo-glycan-containing polymer and method for producing the same
    5.
    发明授权
    Synthetic N-linked sialo-glycan-containing polymer and method for producing the same 失效
    合成的N-连接唾液酸聚糖聚合物及其制备方法

    公开(公告)号:US08450441B2

    公开(公告)日:2013-05-28

    申请号:US12666482

    申请日:2008-06-24

    IPC分类号: C08F251/00 C07H15/06 C12Q1/70

    摘要: A polymer containing an N-linked sialo-glycan wherein a sialo-glycan is condensed to a γ-polyglutamic acid using a chemical compound having an amino group on one end and a carboxyl group on another end and represented by the structural formula (I). Formula (I) (In the formula, Z means a hydroxy group or a residue represented by the formula (II), and n represents an integer of 10 or more, with the proviso that any one or more of the Z's is represented by the formula in (II).) Formula (II) (In the formula, X means a hydroxy group or an acetylamino group, Y1 and Y2 mean a hydroxyl group or an N-acetylneuraminic acid residue, L means a hydrocarbon, an m represents 0 or an integer of 1 or 2, with the proviso that Y1 and Y2 are not the same.)

    摘要翻译: 一种含有N-连接的唾液酸聚糖的聚合物,其中使用一端具有氨基的化合物和另一端的羧基并由结构式(I)表示的唾液酸聚糖与γ-聚谷氨酸缩合, 。 式(I)(式中,Z表示羟基或式(II)表示的残基,n表示10以上的整数,条件是Z中的任一个以上可以由 式(II)中,式(II)(式中,X表示羟基或乙酰氨基,Y1和Y2表示羟基或N-乙酰神经氨酸残基,L表示烃,m表示0 或1或2的整数,条件是Y1和Y2不相同。)

    Heterocyclic derivative and use thereof
    6.
    发明授权
    Heterocyclic derivative and use thereof 失效
    杂环衍生物及其用途

    公开(公告)号:US08461348B2

    公开(公告)日:2013-06-11

    申请号:US12936291

    申请日:2009-04-03

    摘要: The present invention aims to provide a compound having superior pharmacological action, physicochemical properties and the like and useful as an sGC activation drug, or an agent for the prophylaxis and/or treatment of diseases such as hypertension, ischemic cardiac disease, cardiac failure, kidney disease, arteriosclerotic disease, atrial fibrillation, pulmonary hypertension, diabetes, diabetic complications, metabolic syndrome, peripheral arterial obstruction, erectile dysfunction and the like.An sGC activation drug containing a compound represented by the formula (II): wherein each symbol is as defined in the specification, or a salt thereof, as an active ingredient.

    摘要翻译: 本发明旨在提供具有优异的药理作用,理化特性等并可用作sGC活化药物或用于预防和/或治疗高血压,缺血性心脏病,心力衰竭,肾脏等疾病的药剂的化合物 疾病,动脉硬化疾病,心房颤动,肺动脉高压,糖尿病,糖尿病并发症,代谢综合征,外周动脉阻塞,勃起功能障碍等。 含有由式(II)表示的化合物的sGC活化药物:其中每个符号如说明书中所定义,或其盐作为活性成分。